RYBELSUS 7MG – Semaglutide 7mg
Product Name: RYBELSUS 7MG
Active Ingredient: Semaglutide 7mg
Dosage Form: Tablet
Drug Class: GLP-1 receptor agonist
Prescription Status: Prescription medicine
RYBELSUS 7MG contains Semaglutide 7mg, an oral GLP-1 receptor agonist used to improve blood glucose control in adults with type 2 diabetes, alongside diet and exercise. Semaglutide may also reduce appetite and food intake, which can result in weight loss in some patients.
- Estimated Delivery : Up to 4 business days
- Free Shipping & Returns : On all orders over $200
RYBELSUS 7MG contains semaglutide 7mg, a GLP-1 receptor agonist that helps regulate blood glucose and appetite.
Semaglutide mimics the action of naturally occurring GLP-1. It increases glucose-dependent insulin secretion, reduces glucagon secretion and slows gastric emptying. These effects can improve blood glucose control and may reduce food intake and body weight.
RYBELSUS 7MG is generally a maintenance-strength dose, following the initial 3mg treatment period. The appropriate dose depends on individual response and tolerability.
Product Information
| Attribute | Details |
|---|---|
| Brand | RYBELSUS |
| Strength | 7mg |
| Active Ingredient | Semaglutide |
| Dosage Form | Tablet |
| Drug Class | GLP-1 receptor agonist |
| Route | Oral |
| Primary established use | Type 2 diabetes mellitus |
| Common maintenance dose | 7mg once daily |
| Initial dose | 3mg once daily |
| Prescription | Prescription required |
| Weight-related effect | Reduced appetite/weight loss may occur |
Uses
RYBELSUS 7MG may be prescribed to improve blood glucose control in adults with:
- Type 2 diabetes mellitus
- Elevated blood glucose requiring pharmacological treatment
It is used together with appropriate diet and physical activity.
Semaglutide may also lead to reduced appetite and weight loss, but this does not mean that Rybelsus 7mg should automatically be marketed as an approved weight-loss medicine.
RYBELSUS is not insulin and is not indicated for type 1 diabetes.
How Semaglutide Works
Semaglutide activates GLP-1 receptors and produces several effects:
- Increases insulin secretion when blood glucose is elevated
- Reduces glucagon secretion when blood glucose is elevated
- Slows gastric emptying
- Influences appetite and food intake
These actions help improve glycemic control and may contribute to weight reduction.
Dosage
RYBELSUS treatment generally begins with 3mg once daily to help the body adjust to the medicine.
After the initial treatment period, the dose may be increased to 7mg once daily according to the prescribing information and the patient’s response and tolerability.
Do not increase the dose without medical supervision.
How to Take RYBELSUS 7MG
Proper administration is important because oral semaglutide has specific absorption requirements.
- Take once daily.
- Take it on an empty stomach when you first wake up.
- Take it with no more than approximately 120 mL (4 ounces) of plain water.
- Swallow the tablet whole.
- Do not split, crush or chew the tablet.
- Wait at least 30 minutes before eating, drinking anything other than plain water, or taking other oral medicines.
Weight-Management Information
Semaglutide can affect appetite and food intake and may result in weight loss.
Possible effects include:
- Reduced appetite
- Increased feeling of fullness
- Reduced food intake
- Slower gastric emptying
- Reduction in body weight in some patients
Individual results vary.
| Pills | 30, 60, 90, 180 |
|---|








Reviews
There are no reviews yet.